HNF1B and renal cysts and diabetes syndrome: Regarding the previously described variant, the disease penetrance of this variant was 12.5% and none of the carriers showed the special clinical manifestations for Renal Cysts and Diabetes Syndrome (RCAD) related to HNF1B-MODY3,30.